期刊文献+

生活干预联合拉西地平治疗老年高血压的疗效分析 被引量:2

Efficacy analysis of the treatment of senile high blood pressure with life intervention joint lacidipine
暂未订购
导出
摘要 目的分析生活干预联合拉西地平治疗老年高血压的疗效和安全性。方法将75例老年高血压患者随机分成两组。对照组给予拉西地平治疗,治疗组在对照组的基础上加用生活干预措施。两组均连续用药12个月。监测治疗前后血压、血糖、血脂,评价降压疗效,记录不良反应。结果治疗组降压疗效总有效率为92.11%,明显高于对照组(62.16%),两组比较差异有统计意义(P<0.05);两组治疗后血压显著改善,与治疗前比较差异有统计意义(P<0.05),且治疗组优于对照组(P<0.05);治疗组血糖和血脂明显改善,与对照组比较,差异有统计意义(P<0.05);两组未发现不良反应。结论生活干预联合拉西地平治疗老年高血压安全有效,值得临床重视和社区推广。 Objective To analyze the efficacy and safety of the old high blood pressure patients treated with life intervention joint lacidipine.Methods Seventy five cases of old patients with high blood pressure were randomly divided into two groups.The control group were given lacidipine treatment,the treatment group were given the life intervention measures on the base of the control group.Both groups used drug for 12 months continuously.The blood pressure,blood sugar,blood fat were monitored before and after treatment,hypertension effect was evaluated,the adverse reaction was recorded.Results The total effective rate of antihypertensive effects in the treatment group was 92.11%,which was significantly higher than those in the control group (62.16%),with significant differences between the two groups (P 0.05);Two groups of blood pressure after treatment improved markedly with significant difference compared with treatment before (P 0.05),and the treatment group was better than that of control group (P 0.05);Blood sugar and blood fat in the treatment group obviously improved,with significant difference compared with control group (P 0.05);Two groups was not found to adverse reactions.Conclusion Intervention life joint lacidipine to treat the old high blood pressure patients is safe and effective,and is worthy of clinical attention and community promotion.
出处 《中国当代医药》 2012年第13期32-33,35,共3页 China Modern Medicine
关键词 高血压 生活干预 拉西地平 老年 High blood pressure Life intervention Lacidipine The old
  • 相关文献

参考文献6

二级参考文献17

  • 1段留法,郑秋甫,张丽萍,曾强,范英鲜,唐朝枢.自发性高血压大鼠血管内皮功能不全发生机理实验研究[J].中国康复理论与实践,2005,11(6):413-414. 被引量:7
  • 2李建军.高血压可能是一种炎症相关性疾病[J].高血压杂志,2005,13(9):526-527. 被引量:46
  • 3[1]Michcli D,Ritti E,Toson G,et al.Phammecology of lacidipine-A vasoselective calcium antagonist[J].Cardiovascular Phanncol,1991,17(Suppl.4):1-8.
  • 4[2]Hall ST,Harding SM,Evans GL,et al.Clinical Pharmacology of lacidily-ine[J].Cardiovascular Pharlmacol,1991,17(Suppl.4):9-13.
  • 5[3]Shciban,Arosio E,Montesi G,et al.Remodeling of left ventricular biometry and function induced by lacidipine and nitrendipine SR in mild to moderate hypertension[J].Cardiovascular Pharmacol,1991,17(Suppl.4):68-74.
  • 6[1]Marshall HJ,Beevers DG.Lisinopril in the treatment of uncomplicated essential hypertension,Rev Contemp Pharmacother,1993,4:80.
  • 7[2]Lindsay D,Johnson FN.Use of lisinopril in the treatment of patients with heart failure.Rev contemp pharmacother,1993,4:107.
  • 8[3]Myers MG.Trough-to-peak ratio and 24-hour blood pressure control Mthodologic issue.AM J Hypertens,1995,8:214.
  • 9[4]Dahlof C.Well-being(quality of life)in connection with hypertensive treatment.Clin Cardiol,1991,14:79.
  • 10[5]Prickering TG.The clinical significance of diumal blood pressure Variation:dippers and nondippers.Circulation,1990,81:700.

共引文献1450

同被引文献15

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部